- Home
- INHD vs ATHA Comparison
INHD vs ATHA Comparison
Compare INHD & ATHA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- ATHA
- Stock Information
- Founded
- INHD 2019
- ATHA 2011
- Country
- INHD United States
- ATHA United States
- Employees
- INHD N/A
- ATHA N/A
- Industry
- INHD
- ATHA Medicinal Chemicals and Botanical Products
- Sector
- INHD
- ATHA Health Care
- Exchange
- INHD Nasdaq
- ATHA Nasdaq
- Market Cap
- INHD 19.8M
- ATHA 21.0M
- IPO Year
- INHD 2023
- ATHA 2020
- Fundamental
- Price
- INHD $5.40
- ATHA $0.25
- Analyst Decision
- INHD
- ATHA Buy
- Analyst Count
- INHD 0
- ATHA 4
- Target Price
- INHD N/A
- ATHA $11.25
- AVG Volume (30 Days)
- INHD 12.4K
- ATHA 214.9K
- Earning Date
- INHD 05-12-2025
- ATHA 05-14-2025
- Dividend Yield
- INHD N/A
- ATHA N/A
- EPS Growth
- INHD N/A
- ATHA N/A
- EPS
- INHD N/A
- ATHA N/A
- Revenue
- INHD $916,878.00
- ATHA N/A
- Revenue This Year
- INHD N/A
- ATHA N/A
- Revenue Next Year
- INHD N/A
- ATHA N/A
- P/E Ratio
- INHD N/A
- ATHA N/A
- Revenue Growth
- INHD 39.48
- ATHA N/A
- 52 Week Low
- INHD $3.00
- ATHA $0.25
- 52 Week High
- INHD $9.10
- ATHA $3.67
- Technical
- Relative Strength Index (RSI)
- INHD 71.00
- ATHA 26.66
- Support Level
- INHD $4.30
- ATHA $0.25
- Resistance Level
- INHD $4.81
- ATHA $0.31
- Average True Range (ATR)
- INHD 0.28
- ATHA 0.03
- MACD
- INHD 0.10
- ATHA -0.00
- Stochastic Oscillator
- INHD 91.68
- ATHA 0.00
Stock Price Comparison Chart: INHD vs ATHA
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About ATHA Athira Pharma Inc.
Athira Pharma Inc is a late clinical-stage biopharmaceutical company focused on developing small molecules engineered to restore neuronal health and slow neurodegeneration. Its pipeline candidates are; Fosgonimeton (ATH-1017) a subcutaneously administered, small molecule positive modulator of the HGF/MET system for CNS disorders, ATH-1020 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system. ATH-1105 is a novel small molecule compound designed to be an orally available once-daily treatment, to enhance the HGF/MET system, and several other compounds in preclinical discovery and development for neurodegenerative diseases, including ATH-1018 and ATH-1019.